TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
ABVX

Abivax S.A.

Healthcare · Biotechnology

91.10$ -4.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

Abivax S.A. (ABVX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Revenue" came in at 0.0 million EUR. Tick rows to compare them in a chart.

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Income Statement ABVX
Line item Q2 14 Q4 14 Q2 15 Q4 15 Q2 16 Q4 16 Q2 17 Q4 17 Q2 18 Q4 18 Q2 19 Q4 19 Q2 20 Q4 20 Q2 21 Q4 21 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 LTM
– 0.2 0.3 -0.1 0.1 0.0 0.0 0.4 0.5 0.3 – – – – – – 2.2 – 2.2 – 2.2 2.3 0.0 3.4 0.0 7.4 0.0 2.0 0.0 -2.0 0.0 0.0
0.5 2.8 6.8 7.9 8.8 5.9 5.4 5.1 6.9 8.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 – 0.0 – 0.3 0.4 – – – – – – – 1.0 – –
-0.5 -2.6 -6.5 -8.0 -8.6 -5.9 -5.4 -4.7 -6.4 -8.2 0.0 0.0 0.0 0.0 0.0 -0.1 2.2 – 2.2 – 2.2 2.3 – 3.4 – 7.4 – 2.0 – -3.0 – –
– 3.8 7.0 8.3 9.2 6.3 5.7 5.1 7.1 8.8 15 14 13 21 24 23 15 – 33 – 33 71 36 29 43 39 39 39 55 44 50 188
– – – – – – – – – – – – – – – 2.3 2.2 – 5.3 – 6.6 16 10 12 8.2 8.7 8.9 8.9 27 28 8.0 72
0.3 1.7 1.6 2.1 2.0 1.7 2.0 2.0 2.2 2.4 17 16 16 23 27 26 28 – 38 – 39 92 45 35 50 47 47 46 81 200 56 383
-0.8 -4.3 -8.1 -10 -11 -7.6 -7.4 -6.7 -8.6 -11 -17 -16 -16 -23 -27 -26 -19 – -39 – -40 -92 -45 -35 -50 -47 -47 -46 -81 -200 -56 -383
0.0 0.1 0.1 – – – – – – 0.5 0.6 1.0 1.0 1.4 1.0 2.2 2.1 – 1.8 – 15 5.7 2.4 3.8 4.7 4.5 4.5 3.5 4.2 15 2.5 26
-0.8 -5.1 -8.3 -11 -10 -7.5 -7.2 -6.7 -8.6 -11 -18 -17 -15 -25 -18 -27 -32 – -43 – -54 -98 -43 -39 -55 -52 -52 -48 -153 -282 -48 -532
-0.1 -0.7 -1.1 -1.8 -2.1 -1.4 -1.7 -1.0 -1.4 -2.6 -3.8 -0.5 0.0 -2.6 -1.6 -2.6 -2.2 1.1 -2.3 – -2.2 -2.3 – – – – – – – 5.8 – –
-0.7 -4.4 -7.2 -8.8 -8.3 -6.0 -5.5 -5.7 -7.2 -8.6 -14 -16 -15 -22 -17 -25 -30 – -40 – -52 -96 -43 -39 -55 -52 -52 -48 -153 -288 -48 -538
– -4.3 -8.1 -10 -11 -7.6 -7.4 -6.7 -8.5 -11 -17 -16 -16 -23 -27 -25 -15 – -36 – -39 -92 – -35 – -48 – -45 – -256 – –

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?